AcouSort publishes Q1 2026 interim report
The company reports net sales TSEK 2,147, loss before tax TSEK -2,369, Werfen prepayment of about USD 1.3 million, and equity ratio improved to 52%.
See the latest news and media coverage for AcouSort. We track all announcements, press releases, and industry mentions in real time, all in one place.
Acoustofluidics-based cell and sample processing solutions
acousort.comLast updated
In short: AcouSort received a $1.3 million royalty prepayment from Werfen, secured a new veterinary diagnostic order, and narrowed its first-quarter losses.
The company reports net sales TSEK 2,147, loss before tax TSEK -2,369, Werfen prepayment of about USD 1.3 million, and equity ratio improved to 52%.
The report is available as a PDF on the company's website and includes financial performance for the fiscal year.
Werfen prepays minimum royalties for 2027-2028, totaling USD 1.3 million with 2026 royalties, funding AcouSort into 2027.
Net sales rise to TSEK 6,853. Losses narrow. New partnerships signed. Equity ratio improves to 91%.
The "Company" or "AcouSort" refers to AcouSort AB (publ) with corporate registration number 556824-1037. First quarter 2026 for the Group Net sales amounted to TSEK...
Acousort, a technology company focused on medtech/biotech, reports an operating result for the first quarter of 2026 of -3.0 million kronor (-3.3).
The Hebrew University of Jerusalem has acquired the AcouTrap system from AcouSort AB for an amount of 0.04 million euros ...
GEA reports on the total number of shares, voting rights and exercisable voting rights as of 31/03/2026. Visit www.gea.fr for more information...
Track AcouSort and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.